New Zealand to consider batch of reclassifications

25 June 2020 - Deborah Wilkes

Changes to the status of human papillomavirus (HPV) vaccine, pholcodine and cetirizine will be considered at the next meeting of New Zealand's Medicines Classification Committee (MCC).